Profile for Hong Kong Patent: 1183910
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Hong Kong Patent: 1183910
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Dec 29, 2027 | Novartis | LEQVIO | inclisiran sodium |
| ⤷ Start Trial | May 10, 2027 | Novartis | LEQVIO | inclisiran sodium |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
